Loading insider details...
Beta
Latest Form 4 (Aug 28, 2026): Exercise/Conversion of 1,500 IMVT shares, $12.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 28, 2026 | Immunovant, Inc. (IMVT) | Exercise/Conversion | 1,500 | $12.6K |
| Jul 24, 2026 | Immunovant, Inc. (IMVT) | Exercise/Conversion | 1,500 | $12.6K |
| Jun 26, 2026 | Immunovant, Inc. (IMVT) | Exercise/Conversion | 1,500 | $12.6K |
| Jun 16, 2026 | Immunovant, Inc. (IMVT) | Exercise/Conversion | 1,500 | $12.6K |
| May 21, 2026 | Immunovant, Inc. (IMVT) | Exercise/Conversion | 6,000 | $50.6K |
| Apr 9, 2026 | Immunovant, Inc. (IMVT) | Grant/Award | 13,880 | n/a |
| Apr 3, 2025 | Immunovant, Inc. (IMVT) | Grant/Award | 16,188 | n/a |
| Dec 4, 2024 | Immunovant, Inc. (IMVT) | Sale | 7,750 | $221.2K |
| Apr 4, 2024 | Immunovant, Inc. (IMVT) | Grant/Award | 11,255 | n/a |
| Mar 18, 2024 | Karuna Therapeutics, Inc. (KRTX) | Disposition to Issuer | 990 | $326.7K |